The DOI matches its Crossref record; 153 of the 166 references it cites were found in a registry or an index; 29 of the 64 sources its claims cite were checked for support.
Pathophysiological Aspects of Alcohol Metabolism in the Liver
Open accessAbstract
Alcoholic liver disease (ALD) is a globally prevalent chronic liver disease caused by chronic or binge consumption of alcohol. The liver is the major organ that metabolizes alcohol; therefore, it is particularly sensitive to alcohol intake. Metabolites and byproducts generated during alcohol metabolism cause liver damage, leading to ALD via several mechanisms, such as impairing lipid metabolism, intensifying inflammatory reactions, and inducing fibrosis. Despite the severity of ALD, the development of novel treatments has been hampered by the lack of animal models that fully mimic human ALD. To overcome the current limitations of ALD studies and therapy development, it is necessary to understand the molecular mechanisms underlying alcohol-induced liver injury. Hence, to provide insights into the progression of ALD, this review examines previous studies conducted on alcohol metabolism in the liver. There is a particular focus on the occurrence of ALD caused by hepatotoxicity originating from alcohol metabolism.
Overview
CoChat Summary
TL;DR
This paper is a narrative review of how alcohol metabolism in the liver drives alcoholic liver disease (ALD), with emphasis on toxic oxidative metabolites such as acetaldehyde and ROS. It argues that these metabolites promote steatosis, inflammation, fibrosis, and liver cancer, and that better human-relevant models are needed to develop therapies.
Key findings
- Alcohol is mainly metabolized in the liver by the oxidative pathway: alcohol dehydrogenase (ADH) converts alcohol to acetaldehyde, and aldehyde dehydrogenase (ALDH) converts acetaldehyde to acetate; more than 90% of absorbed alcohol is transported to the liver, and less than 10% is excreted in breath, sweat, and urine.
- The paper states that alcoholic fatty liver is observed in up to 90% of heavy drinkers, and that excessive alcohol consumption leads to a 3- to 10-fold increase in hepatocellular carcinoma (HCC) risk and accounts for 30% of HCC cases worldwide.
- Chronic alcohol exposure disrupts the gut barrier, promotes lipopolysaccharide translocation, and activates Kupffer cells and the TLR4/MAPK/NF-κB axis; the paper also reports that TLR4 knockout mice were resistant to alcohol-induced hepatic steatosis.
- Alcohol metabolism-derived acetaldehyde and ROS promote fibrosis and cancer by damaging DNA/proteins, activating hepatic stellate cells, and impairing repair; the paper notes that ALDH2 deficiency is associated with higher liver-cancer risk in heavy drinkers, and that 30–40% of the Asian population has ALDH2 deficiency.
Methods
- Narrative review of previous studies on alcohol metabolism in the liver and its role in ALD pathogenesis; not an original experimental study.
- The paper synthesizes findings from human studies, rodent studies, and in vitro/ex vivo models of ALD.
- It summarizes mechanisms across alcohol metabolism, lipid accumulation, immune dysregulation, fibrosis, carcinogenesis, and model systems used for ALD research.
Limitations
- Stated in the paper: there is a lack of ALD patient samples and reliable animal models that reflect human ALD, which hampers understanding and therapy development.
- Stated in the paper: many candidate therapies tested in animal models are controversial or not proven clinically, and the paper notes that no FDA-approved drug exists for ALD.
- Evident from the text: because this is a review, it does not present new primary data or a formal systematic search/selection protocol, so its conclusions depend on the studies it chose to summarize.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
20 Valid · 1 Not valid · 9 Not checked · 6 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Alcoholic liver disease (ALD) is a globally prevalent chronic liver disease caused by chronic or binge consumption of alcohol.”
§ Pathophysiological Aspects of Alcohol Metabolism in the Liver > Abstract
What the sources say
- Partly supportedcites [4] Zakhari, 2007, Determinants of alcohol use and abuse: Impact of quantity and frequency patterns on liver disease, Hepatology sourceExperimental — accuracy not yet measured
The etiologic part is supported: the 'Drinking Pattern and Alcohol Abuse/Dependence' section states that drinking too much and too often over a long period results in ALD (fatty liver, steatohepatitis, fibrosis, cirrhosis), and 'Quantity/Frequency, Comorbid Conditions, and Liver Disease' notes acute alcoholic hepatitis in chronic alcoholics and in moderate drinkers after a binge; the Abstract likewise ties variability in ALD to the pattern of drinking (daily versus binge). However, our copy never describes ALD as a globally prevalent chronic liver disease — it consistently restricts its epidemiology to the United States ('Alcohol-induced disorders... are major health problems in the United States'; NESARC, cirrhosis mortality in the US), so the 'globally prevalent' qualifier attributed to this source is not supported (searched: worldwide/global prevalence, global burden of liver disease). (LLM, conf=0.72)
- Not checked — no full text of the sourcecites [9] Lieber, 2000, Alcoholic liver disease: New insights in pathogenesis lead to new treatments, J. Hepatol. source
- Partly supportedcites [10] Cederbaum, 2012, Alcohol metabolism, Clin. Liver Dis. sourceExperimental — accuracy not yet measured
The “Zonal Metabolism of Alcohol in the Hepatic Acinus” section (page unavailable) links chronic alcohol treatment to liver injury. Our copy does not establish that binge consumption causes alcoholic liver disease; a search for “binge” found no passage addressing that part of the claim. (LLM, conf=0.85)
- Partly supportedcites [11] Gao, 2011, Alcoholic liver disease: Pathogenesis and new therapeutic targets, Gastroenterology sourceExperimental — accuracy not yet measured
The Abstract describes alcohol as a major cause of chronic liver disease, and “Spectrum, Risk Factors, and Comorbidities” links heavy drinking to ALD. That section also compares daily heavy drinking with episodic or binge drinking, but it does not establish that binge drinking alone causes ALD. (LLM, conf=0.82)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The levels of pro-inflammatory cytokines, such as tumor necrosis factor alpha (TNFα), interleukin (IL)-1β, and IL-8, are upregulated in patients with ALD [70].”
§ Pathophysiological Aspects of Alcohol Metabolism in the Liver > 3. Oxidative Ethanol Metabolites Are Involved in ALD Pathogenesis > 3.2. Dysregulated Immune System
What the sources say
- Partly supportedcites [70] Gao, 2019, Inflammatory pathways in alcoholic steatohepatitis, J. Hepatol. sourceExperimental — accuracy not yet measured
The “Cytokines and chemokines” section reports that many cytokines are highly upregulated in liver and serum from patients with severe alcoholic hepatitis, and the “Hepatocytes” section specifically reports elevated IL-8 in those patients. It says cytokines are only probably elevated in mild and moderate ALD, so it does not establish the claim without that severity qualifier. It also classifies IL-8 as a chemokine rather than a cytokine. (LLM, conf=0.87)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“It also binds to a variety of proteins to form acetaldehyde adducts, which distorts liver function and structure [37,38].”
§ Pathophysiological Aspects of Alcohol Metabolism in the Liver > 2. Alcohol Metabolism Ingested alcohol is absorbed through the stomach and intestines. Less than 10% of absorbed alcohol is excreted in breath, sweat, and urine. This means that more than 90% of the absorbed alcohol circulates through the body and is eventually transported to the liver via the portal vein [10,25]. Due to the high levels of alcohol metabolizing enzymes in the liver, the liver plays a major role in alcohol metabolism [10]. In the liver, alcohol is metabolized by oxidative and non-oxidative pathways (Figure 1) [26,27]. The oxidative pathway is the major pathway for alcohol metabolism and is composed of two steps. First, alcohol is oxidized to acetaldehyde by alcohol dehydrogenase (ADH), a primary enzyme that converts alcohol to acetaldehyde [28]. Excess alcohol consumption increases the expression and activity of cytochrome P450 2E1 (CYP2E1), not ADH. Activated CYP2E1 promotes the production of acetaldehyde through the formation of reactive oxygen species (ROS) [29,30]. In addition, peroxisomal catalase breaks down alcohol to acetaldehyde, but its action is considered a minor pathway because of its small contribution to alcohol digestion [10,27]. The second step in the oxidative pathway involves the rapid conversion of acetaldehyde to acetate by aldehyde dehydrogenase (ALDH). Acetate is metabolized into carbon dioxide (CO2), fatty acids (FAs), and water (H2O) in peripheral tissues, not the liver [10,27]. The nonoxidative pathway accounts for a minor portion of alcohol metabolism in quantitative terms [31,32,33]. A small amount of alcohol is nonoxidatively conjugated to various endogenous metabolites by different enzymes. For example, enzymatic esterification of alcohol with FAs forms fatty acid ethyl ester (FAEE) and phospholipase D (PLD) catalyzes transphosphatidylation of phosphatidylcholine with ethanol to form phosphatidylethanol (PEth). In addition, alcohol conjugated to glucuronic acid and sulfate generates ethyl glucuronide (EtG) and ethyl sulfate (EtS), respectively [31,32,33]. Products generated during alcohol metabolism damage the liver and act as a driving force of ALD progression from alcoholic steatosis to alcoholic cirrhosis [34,35]. The most well-known toxic compound produced by alcohol metabolism is acetaldehyde [36]. Acetaldehyde interacts directly with DNA and causes point mutations and chromosomal damage. It also binds to a variety of proteins to form acetaldehyde adducts, which distorts liver function and structure [37,38]. These protein adducts upregulate CYP2E1 expression and enhance oxidative stress [39,40]. In addition, Holstege et al. [41] demonstrated that protein adducts contribute to lipid accumulation, inflammation, and fibrosis, playing a key role in the pathogenesis of various stages of ALD. Acetate has been reported to increase portal blood flow by circulating in the bloodstream, although it is less toxic than acetaldehyde [42]. Nonoxidative pathway-derived metabolites, including PEth and FAEE, are also known to cause alcohol toxicity, but the mechanisms have not yet been determined [31,43].
What the sources say
- Not checked — no full text of the sourcecites [37] Tuma, 2003, Dangerous byproducts of alcohol breakdown--focus on adducts, Alcohol Res. Health
- Partly supportedcites [38] Israel, 1986, Monoclonal and polyclonal antibodies against acetaldehyde-containing epitopes in acetaldehyde-protein adducts, Proc. Natl. Acad. Sci. USA sourceExperimental — accuracy not yet measured
The paper’s introduction says acetaldehyde binds covalently to proteins and forms adducts. It says this binding might underlie alcoholic liver damage and could lead to liver-cell injury, but does not establish that the adducts distort liver function and structure. Page numbers are not available in our copy. (LLM, conf=0.88)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The sources with a verdict support this claim; the rest weren’t checked yet, have no full text we could read, or their verdicts aren’t rated yet.
In the paper
“Among these alcohol-damaged organs, the liver is specifically susceptible to damage because the liver is the primary site of alcohol metabolism in the body [9,10].”
§ Pathophysiological Aspects of Alcohol Metabolism in the Liver > 1. Introduction Alcohol has long been closely related to human culture, used as a drug, and considered an indulgence [1,2]. As the consumption of alcoholic beverages increases, it contributes to the significant elevation of morbidity and mortality worldwide [3,4]. In 2018, the World Health Organization (WHO) estimated that alcohol consumption is responsible for three million deaths worldwide annually, accounting for nearly 14% of the total mortality in people aged 20 to 40 years old [5]. In addition to social and psychiatric problems, more than 200 diseases that affect several organs, such as the brain, heart, gastrointestinal tract, and liver, are related to habitual alcohol consumption [6,7,8]. Among these alcohol-damaged organs, the liver is specifically susceptible to damage because the liver is the primary site of alcohol metabolism in the body [9,10]. Alcohol metabolism generates products that damage the liver, resulting in alcoholic liver disease (ALD), a main cause of chronic liver disease [4,9,10,11]. ALD encompasses a broad spectrum of conditions, including alcoholic fatty liver (simple steatosis), alcoholic hepatitis, alcoholic cirrhosis, and liver cancer [4,11,12,13]. Alcoholic fatty liver is defined by fat accumulation in hepatocytes without substantial inflammation, or hepatic fibrosis, and is observed in up to 90% of heavy drinkers [9,11,12,13,14]. Heavy long-term alcohol consumption accelerates the transition of alcoholic fatty liver into alcoholic hepatitis, which is characterized by steatosis, ballooning hepatocytes, and infiltration of neutrophils with or without fibrosis [11,12,13,14,15,16]. Alcoholic cirrhosis is a more severe form of ALD and is defined by disorganized liver architecture with fibrosis [11,12,13,14,15,16]. Although public awareness of the hepatotoxicity caused by alcohol is rising, the trend of alcohol consumption is steadily increasing [4,17]. Alcoholic cirrhosis accounts for approximately half of the deaths related to liver cirrhosis, and alcohol is known to accelerate liver injury in people infected with hepatitis virus [18,19]. To prevent and/or reverse ALD progression, abstinence from alcohol is the most fundamental solution, but it is difficult to suppress the recurrence of drinking because most patients with ALD are alcoholics [20]. Liver transplantation is considered the definitive treatment for ALD, like other end-stage liver diseases [21,22]. However, liver transplantation is a complicated treatment option because it depends on donor availability and demands abstinence from alcohol for at least six months before and after the transplant [23]. There is also an ethical concern that the transplanted liver could be “wasted” on a patient who eventually relapses to drinking and damages the transplanted liver [21]. In addition, there is no effective Food and Drug Administration (FDA)-approved drug for treating patients with ALD [24]. Therefore, it is important to develop effective therapeutics for ALD. Understanding the process of alcohol metabolism in the liver and the actions of hepatotoxic intermediates involved in ALD progression could provide clues for developing ALD treatment strategies. Herein, the metabolic processes of alcohol are summarized, and ALD pathogenesis is reviewed, providing knowledge into the underlying mechanism of ALD.
What the sources say
- Not checked — no full text of the sourcecites [9] Lieber, 2000, Alcoholic liver disease: New insights in pathogenesis lead to new treatments, J. Hepatol. source
- Supportedcites [10] Cederbaum, 2012, Alcohol metabolism, Clin. Liver Dis. source
The First Pass Metabolism of Alcohol in the Stomach section says that, compared with the stomach, the liver has greater levels of alcohol-metabolizing enzymes and likely plays the major role in alcohol metabolism. The Alcohol Metabolism-General Principles section likewise says the principal ethanol-oxidizing enzymes are present to the largest extent in the liver. (LLM, conf=0.94)
plain- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“Heavy long-term alcohol consumption accelerates the transition of alcoholic fatty liver into alcoholic hepatitis, which is characterized by steatosis, ballooning hepatocytes, and infiltration of neutrophils with or without fibrosis [11,12,13,14,15,16].”
§ Pathophysiological Aspects of Alcohol Metabolism in the Liver > 1. Introduction Alcohol has long been closely related to human culture, used as a drug, and considered an indulgence [1,2]. As the consumption of alcoholic beverages increases, it contributes to the significant elevation of morbidity and mortality worldwide [3,4]. In 2018, the World Health Organization (WHO) estimated that alcohol consumption is responsible for three million deaths worldwide annually, accounting for nearly 14% of the total mortality in people aged 20 to 40 years old [5]. In addition to social and psychiatric problems, more than 200 diseases that affect several organs, such as the brain, heart, gastrointestinal tract, and liver, are related to habitual alcohol consumption [6,7,8]. Among these alcohol-damaged organs, the liver is specifically susceptible to damage because the liver is the primary site of alcohol metabolism in the body [9,10]. Alcohol metabolism generates products that damage the liver, resulting in alcoholic liver disease (ALD), a main cause of chronic liver disease [4,9,10,11]. ALD encompasses a broad spectrum of conditions, including alcoholic fatty liver (simple steatosis), alcoholic hepatitis, alcoholic cirrhosis, and liver cancer [4,11,12,13]. Alcoholic fatty liver is defined by fat accumulation in hepatocytes without substantial inflammation, or hepatic fibrosis, and is observed in up to 90% of heavy drinkers [9,11,12,13,14]. Heavy long-term alcohol consumption accelerates the transition of alcoholic fatty liver into alcoholic hepatitis, which is characterized by steatosis, ballooning hepatocytes, and infiltration of neutrophils with or without fibrosis [11,12,13,14,15,16]. Alcoholic cirrhosis is a more severe form of ALD and is defined by disorganized liver architecture with fibrosis [11,12,13,14,15,16]. Although public awareness of the hepatotoxicity caused by alcohol is rising, the trend of alcohol consumption is steadily increasing [4,17]. Alcoholic cirrhosis accounts for approximately half of the deaths related to liver cirrhosis, and alcohol is known to accelerate liver injury in people infected with hepatitis virus [18,19]. To prevent and/or reverse ALD progression, abstinence from alcohol is the most fundamental solution, but it is difficult to suppress the recurrence of drinking because most patients with ALD are alcoholics [20]. Liver transplantation is considered the definitive treatment for ALD, like other end-stage liver diseases [21,22]. However, liver transplantation is a complicated treatment option because it depends on donor availability and demands abstinence from alcohol for at least six months before and after the transplant [23]. There is also an ethical concern that the transplanted liver could be “wasted” on a patient who eventually relapses to drinking and damages the transplanted liver [21]. In addition, there is no effective Food and Drug Administration (FDA)-approved drug for treating patients with ALD [24]. Therefore, it is important to develop effective therapeutics for ALD. Understanding the process of alcohol metabolism in the liver and the actions of hepatotoxic intermediates involved in ALD progression could provide clues for developing ALD treatment strategies. Herein, the metabolic processes of alcohol are summarized, and ALD pathogenesis is reviewed, providing knowledge into the underlying mechanism of ALD.
What the sources say
- Partly supportedcites [11] Gao, 2011, Alcoholic liver disease: Pathogenesis and new therapeutic targets, Gastroenterology sourceExperimental — accuracy not yet measured
The Spectrum, Risk Factors, and Comorbidities section says fatty liver is an early response to heavy drinking and that alcoholic hepatitis may occur in patients with underlying alcoholic liver disease and heavy alcohol intake. The Pathogenesis > AH section says hepatitis develops in patients with steatosis and describes ballooning hepatocytes, neutrophilic infiltration, steatosis, and fibrosis. These passages support the progression and histologic description, but do not establish that long-term heavy drinking accelerates the specific transition from fatty liver to hepatitis. (LLM, conf=0.85)
- Not checked — no full text of the sourcecites [12] Altamirano, 2011, Alcoholic liver disease: Pathogenesis and new targets for therapy, Nat. Rev. Gastroenterol. Hepatol. source
- Not checked — no full text of the sourcecites [13] Schwartz, 2012, Prevalence and natural history of alcoholic liver disease, Clin. Liver Dis. source
- Not checked — no full text of the sourcecites [14] Lieber, 2004, Alcoholic fatty liver: Its pathogenesis and mechanism of progression to inflammation and fibrosis, Alcohol source
- Partly supportedcites [15] Osna, 2017, Alcoholic Liver Disease: Pathogenesis and Current Management, Alcohol Res. sourceExperimental — accuracy not yet measured
The Abstract says steatosis can progress to steatohepatitis, and Modifiers of ALD Risk links long-term alcohol intake to more severe disease, including steatohepatitis. Spectrum of ALD describes ballooning hepatocytes and neutrophilic infiltration. The paper does not establish that heavy drinking accelerates the rate of transition from fatty liver to hepatitis, and it does not explicitly describe hepatitis as occurring with or without fibrosis. (LLM, conf=0.83)
- Not checked — no full text of the sourcecites [16] Askgaard, 2015, Alcohol drinking pattern and risk of alcoholic liver cirrhosis: A prospective cohort study, J. Hepatol. source
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Partly supported
19 more claims · 9 with their cited sources checked
Create a free account to see all 36 claims and to verify the 6 references still open.
- Probably not a substantial claim. 3
- It may state two separate claims as one. 9
- Borderline: one of the tests for a substantial claim is unclear. 1
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Self-check results appear here once an independent check has confirmed them.
Cited works that were retracted
Works this paper cites that were later retracted, from the retraction notices publishers deposit. Major when the notice came out before this paper was published.
Rated major: it would touch a result — a value a result rests on, reported and recomputed p-values on opposite sides of the significance level, two passages that conflict with no sign which is right, or a cited work retracted before this paper was published.
In the paper
“Lin, 2014, Helenalin attenuates alcohol-induced hepatic fibrosis by enhancing ethanol metabolism, inhibiting oxidative stress and suppressing HSC activation, Fitoterapia, 95, 203, 10.1016/j.fitote.2014.03.020”
Cited work 10.1016/j.fitote.2014.03.020 · retracted 2014-06-01 · notice 10.1016/j.fitote.2014.03.020 · this paper published 2021-05-27
Citations
Cites
1 retracted
Lin, X., Zhang, S., Huang, R., Wei, L., Tan, S., Liang, S., Tian, Y., Wu, X., Lu, Z., & Huang, Q. (2014) · Fitoterapia · doi:10.1016/j.fitote.2014.03.020 · Cited by 39
RetractedTranscriptional Regulation by Nrf2
Tonelli, C., Chio, I. I. C., & Tuveson, D. A. (2018) · Antioxidants & Redox Signaling · doi:10.1089/ars.2017.7342 · Cited by 2,192
Alcoholic Liver Disease: Pathogenesis and New Therapeutic Targets
Gao, B., & Bataller, R. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.09.002 · Cited by 1,963
TLR4 enhances TGF-β signaling and hepatic fibrosis
Seki, E., De Minicis, S., Österreicher, C. H., Kluwe, J., Osawa, Y., Brenner, D. A., & Schwabe, R. F. (2007) · Nature Medicine · doi:10.1038/nm1663 · Cited by 1,942
The Role of Oxidative Stress and Antioxidants in Liver Diseases
Li, S., Tan, H.-Y., Wang, N., Zhang, Z.-J., Lao, L., Wong, C.-W., & Feng, Y. (2015) · International Journal of Molecular Sciences · doi:10.3390/ijms161125942 · Cited by 1,835
Alcohol, oxidative stress and free radical damage
Albano, E. (2006) · Proceedings of the Nutrition Society · doi:10.1079/pns2006496 · Cited by 1,215
Mouse model of chronic and binge ethanol feeding (the NIAAA model)
Bertola, A., Mathews, S., Ki, S. H., Wang, H., & Gao, B. (2013) · Nature Protocols · doi:10.1038/nprot.2013.032 · Cited by 1,213
The relation between different dimensions of alcohol consumption and burden of disease: an overview
Rehm, J., Baliunas, D., Borges, G. L. G., Graham, K., Irving, H., Kehoe, T., Parry, C. D., Patra, J., Popova, S., Poznyak, V., et al. (2010) · Addiction · doi:10.1111/j.1360-0443.2010.02899.x · Cited by 1,174
Cederbaum, A. I. (2012) · Clinics in Liver Disease · doi:10.1016/j.cld.2012.08.002 · Cited by 1,145
Molecular mechanisms of alcohol-mediated carcinogenesis
Seitz, H. K., & Stickel, F. (2007) · Nature Reviews Cancer · doi:10.1038/nrc2191 · Cited by 1,138
Research works printed but not linked: 1
- Parkkila, 1998, Early alcoholic liver injury: Formation of protein adducts with acetaldehyde and lipid peroxidation products, and expression of CYP2E1 and CYP3A, Alcohol Clin. Exp. Res., 22, 2118
Cited by
The AMPK pathway in fatty liver disease
Fang, C., Pan, J., Qu, N., Lei, Y., Han, J., Zhang, J., & Han, D. (2022) · Frontiers in Physiology · doi:10.3389/fphys.2022.970292 · Cited by 364
“steatosis, hepatocyte inflation, and neutrophil infiltration with or without fibrosis, and may also lead to the development of fibrosis, which is characterized by excessive deposition of extracellular matrix proteins (Altamirano and Bataller 2011; Hyun et al., 2021).”
BackgroundSelf-citationBenedé-Ubieto, R., Cubero, F. J., & Nevzorova, Y. A. (2024) · Gut Microbes · doi:10.1080/19490976.2024.2331460 · Cited by 242
Lai, W., Zhang, J., Sun, J., Min, T., Bai, Y., He, J., Cao, H., Che, Q., Guo, J., & Su, Z. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.134809 · Cited by 110
Park, J.-S., Rustamov, N., & Roh, Y. (2023) · Antioxidants · doi:10.3390/antiox12111928 · Cited by 93
“Hepatocytes metabolize ethanol through various enzymatic pathways, and alcohol dehydrogenase (ADH) and cytochrome P450 2E1 (CYP2E1) convert ethanol into acetaldehyde, a highly toxic substance that damages liver cells and impairs DNA [14].”
BackgroundHepatocellular carcinoma and lipid metabolism: Novel targets and therapeutic strategies
Cao, L.-Q., Xie, Y., Fleishman, J. S., Liu, X., & Chen, Z. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217061 · Cited by 84
Metadata
- Authors
- Hyun, J., Han, J., Lee, C., Yoon, M., & Jung, Y.
- Affiliations
- Dankook University (KR)
- Pusan National University (KR)
- Department of Surgery, Division of Hepatobiliary and Pancreas Surgery, Biomedical Research Institute, Pusan National University, Pusan 46241, Korea
- Corresponding author
- Jung, Youngmi
- Venue
- International Journal of Molecular Sciences
- Publisher
- MDPI AG
- Published
- 2021-05-27
- Volume
- 22
- Issue
- 11
- Pages
- 5717
- ISSN
- 1422-0067 (ISSN-L)
- PMC
- PMC8197869
- OpenAlex
- W3164074301
- Semantic Scholar
- 41c781dac1404a710a16337f98b2ba3511aa6b80
- Cited by
- 324
- References
- 166
- Citations by year
- 2026: 56 · 2025: 93 · 2024: 74 · 2023: 66 · 2022: 28 · 2021: 6
- FWCI
- 7.62
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- International Journal of Molecular Sciences (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Research Foundation of Korea (2021R1C1C1003904)
- Biomedical Research Institute Grant of Pusan National University Hospital (20200216)
- Topics
- Health Sciences › Medicine › Pathology and Forensic Medicine › Alcohol Consumption and Health Effects
- Health Sciences › Medicine › Hepatology › Liver physiology and pathology
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmacology › Drug-Induced Hepatotoxicity and Protection
- Keywords
- alcoholic liver disease, alcohol metabolism, hepatotoxicity, liver injury, lipid metabolism, inflammation, liver fibrosis, animal models of alcoholism
- MeSH terms
- Ethanol, Animals, Disease Susceptibility, Humans, Immune System, Liver, Liver Cirrhosis, Liver Diseases, Alcoholic, Liver Neoplasms, Inactivation, Metabolic, Oxidation-Reduction, Sensitivity and Specificity, Reactive Oxygen Species, Hepatocytes, Lipid Metabolism, Metabolic Networks and Pathways, Immunomodulation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (qwen3.8-omni-flash and gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Pathophysiological Aspects of Alcohol Metabolism in the Liver. https://app.cochat.ai/papers/10.3390/ijms22115717
- The paper
- Hyun, J., Han, J., Lee, C., Yoon, M., & Jung, Y. (2021). Pathophysiological Aspects of Alcohol Metabolism in the Liver. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms22115717
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.